Literature DB >> 11838616

Risk management of HBsAg or anti-HCV positive healthcare workers in hospital.

A Mele1, G Ippolito, A Craxì, R C Coppola, N Petrosillo, M Piazza, V Puro, M Rizzetto, L Sagliocca, G Taliani, A Zanetti, M Barni, E Bianco, E Bollero, A Cargnel, M Cattaneo, M Chiaramonte, E Conti, R D'Amelio, D M De Stefano, S Di Giulio, E Franco, G Gallo, M Levrero, E Mannella, S M Erli, F Milazzo, A Moiraghi, R Polillo, D Prati, P Ragni, E Sagnelli, P Scognamiglio, L Sommella, T Stroffolini, T Terrana, G Tosolini, E Vitiello, L Zanesco, V Ziparo, C Maffei, M L Moro, R Satolli, G Traversa.   

Abstract

Recommendations are made for controlling the transmission of the hepatitis B and hepatitis C viruses from healthcare workers to patients. These recommendations were based both on the literature and on experts' opinions, obtained during a Consensus Conference. The quality of the published information and of the experts' opinions was classified into 6 levels, based on the source of the information. The recommendations can be summarised as follows: all healthcare workers must undergo hepatitis B virus vaccination and adopt the standard measures for infection control in hospitals; healthcare workers who directly perform invasive procedures must undergo serological testing and the evaluation of markers of viral infection. Those found to be positive for: 1) HBsAg and HBeAg, 2) HBsAg and hepatitis B virus DNA, or 3) anti-hepatitis C virus and hepatitis C virus RNA must abstain from directly performing invasive procedures; no other limitations in their activities are necessary. Infected healthcare workers are urged to inform their patients of their infectious status, although this is left to the discretion of the healthcare worker; whose privacy is guaranteed by law. If exposure to hepatitis B virus occurs, the healthcare worker must undergo prophylaxis with specific immunoglobulins, in addition to vaccination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11838616     DOI: 10.1016/s1590-8658(01)80698-8

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

2.  Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.

Authors:  Antony P Black; Keooudomphone Vilivong; Phonethipsavanh Nouanthong; Chanthasone Souvannaso; Judith M Hübschen; Claude P Muller
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

3.  Hepatitis B virus infected health care workers in The Netherlands, 2000-2008.

Authors:  T J Daha; M A J Bilkert-Mooiman; C Ballemans; G Frijstein; J N Keeman; R A de Man; J E van Steenbergen; G Weers-Pothoff; H L Zaaijer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-07       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.